Grabosch, et al. demonstrated that cisplatin induced PD-L1 expression on murine ovarian cancer partly via the cGAS/STING pathway and the combination of cisplatin with anti-PD-L1 improved the overall survival of tumor-bearing mice [95]. The gene discussed is CD274; the disease is ovarian cancer.